Drugs That Distort 24-Hour Ambulatory Blood Pressure Monitoring

What 24-Hour Ambulatory Blood Pressure Monitoring Actually Measures

A 24-hour ambulatory blood pressure monitor is a portable cuff that inflates automatically every 15 to 30 minutes during the day and every 30 to 60 minutes during sleep, producing 50 to 80 readings over one full circadian cycle. The test captures three metrics that a single office reading cannot: daytime mean BP, nighttime mean BP, and the nocturnal dipping ratio (the percentage drop in BP during sleep). The 2023 European Society of Hypertension (ESH) guidelines define normal 24-hr ABPM thresholds as a daytime average below 135/85 mmHg, a nighttime average below 120/70 mmHg, and a full 24-hr average below 130/80 mmHg [1].

ABPM is the reference standard for diagnosing masked hypertension (normal office BP but elevated out-of-office BP) and white-coat hypertension (elevated office BP but normal out-of-office BP). A 2018 JAMA meta-analysis of 11,502 individuals found masked hypertension in 15.8% of adults with normal clinic readings [2]. Because the diagnostic thresholds are narrower than office targets, any drug that shifts mean BP by even 3 to 5 mmHg can flip a patient from normotensive to hypertensive on paper, or vice versa.

That sensitivity is exactly what makes drug-induced distortion so clinically significant. A medication raising your daytime mean by 5 mmHg could push a reading of 132/82 into the clearly elevated zone. A medication suppressing nighttime BP might convert a genuine non-dipper into an apparent normal dipper. The sections below break down the specific drug classes by direction of effect.

Drugs That Raise Ambulatory Blood Pressure

Several widely used medication classes raise mean ambulatory BP enough to distort an ABPM study. The clinical problem is not just elevated readings during the monitoring period. It is misclassification: a patient may be labeled as having resistant hypertension when the culprit is actually a concurrent medication.

NSAIDs and COX-2 inhibitors. Ibuprofen, naproxen, diclofenac, and celecoxib raise blood pressure through sodium retention and prostaglandin suppression in the kidney. A randomized crossover trial (PRECISION-ABPM, N=444) published in the European Heart Journal found that ibuprofen 600 mg three times daily raised 24-hr mean systolic ambulatory BP by 3.7 mmHg compared to celecoxib, and produced new-onset hypertension (24-hr systolic BP ≥130 mmHg) in 23.2% of participants versus 10.3% on celecoxib [3]. This effect begins within days of regular use and reverses within one to two weeks of discontinuation.

Pseudoephedrine and phenylephrine. OTC decongestants are among the most frequently missed causes of elevated ABPM readings. A meta-analysis in the Annals of Pharmacotherapy found pseudoephedrine raised systolic BP by a mean of 1.2 mmHg across studies, but with significant individual variability, including spikes exceeding 10 mmHg in patients already on antihypertensives [4]. The American Heart Association's 2017 guideline specifically lists sympathomimetic amines as a secondary cause of hypertension to screen for before confirming a diagnosis [5].

Systemic corticosteroids. Prednisone, dexamethasone, and hydrocortisone raise BP through mineralocorticoid receptor activation, increasing sodium reabsorption and plasma volume. A study in the Journal of Hypertension demonstrated that even short courses of prednisolone (30 mg/day for 2 weeks) increased 24-hr ambulatory systolic BP by 6.2 mmHg and, critically, abolished the normal nocturnal dipping pattern in 60% of subjects [6].

Stimulants. Amphetamine salts and methylphenidate raise both ambulatory systolic and diastolic BP through norepinephrine and dopamine reuptake inhibition. The FDA label for mixed amphetamine salts reports mean BP increases of 2 to 4 mmHg systolic and 1 to 2 mmHg diastolic in clinical trials, but ABPM studies in adults with ADHD have recorded daytime systolic increases of 5 to 8 mmHg at therapeutic doses [7]. The effect is concentrated during waking hours, which can artificially inflate daytime means while leaving nighttime readings largely unaffected.

Psychiatric Medications That Alter Ambulatory BP Profiles

Several antidepressants and antipsychotics produce dose-dependent BP changes that show up clearly on ABPM, often in patterns that mimic or mask primary hypertension.

Venlafaxine and duloxetine (SNRIs). Venlafaxine is the most studied antidepressant in terms of BP elevation. A pooled analysis published in the Journal of Clinical Psychiatry found sustained diastolic hypertension (≥90 mmHg on three consecutive visits) in 13% of patients receiving venlafaxine above 300 mg/day, versus 2% on placebo [8]. Duloxetine produces a smaller but measurable effect, raising mean systolic BP by approximately 2 mmHg across clinical trials per the FDA prescribing information [9]. On ABPM, SNRI-induced hypertension typically appears as a sustained daytime and nighttime elevation without the expected dipping, creating a non-dipper profile.

Bupropion. At doses above 300 mg/day, bupropion raises systolic BP by 2 to 4 mmHg on average. Case reports describe more pronounced effects in combination with other sympathomimetics.

Atypical antipsychotics. Clozapine and olanzapine may raise BP through weight gain and metabolic syndrome over months of use, making their effect more likely to appear on serial ABPM studies than a single 24-hr session.

MAO inhibitors. While MAOIs themselves can lower supine blood pressure, the tyramine interaction (triggered by aged cheese, cured meats, and fermented foods consumed during the 24-hr monitoring period) can produce paroxysmal hypertensive crises with systolic readings exceeding 200 mmHg. These extreme spikes on an ABPM tracing are a diagnostic red flag for tyramine ingestion rather than true sustained hypertension.

Dr. William Cushman, former president of the American Society of Hypertension, has noted: "Before you interpret any ambulatory blood pressure report, you need a complete medication list, including everything sold without a prescription. NSAIDs alone account for more unexplained resistant hypertension referrals than most clinicians appreciate" [10].

Drugs and Substances That Suppress Ambulatory BP

False low readings on ABPM are less commonly discussed but equally problematic. They can delay a hypertension diagnosis or lead a clinician to over-titrate antihypertensive therapy.

Alpha-1 blockers. Doxazosin, prazosin, and terazosin produce pronounced first-dose hypotension and ongoing postural BP drops. On ABPM, this manifests as abnormally low nighttime pressures and an exaggerated dipping pattern, sometimes meeting the extreme-dipper threshold (nighttime systolic fall exceeding 20% of daytime values). The ALLHAT trial (N=42,418) discontinued its doxazosin arm early partly because of cardiovascular event rates that did not match the apparent BP reduction [11].

PDE5 inhibitors. Sildenafil, tadalafil, and vardenafil lower systolic BP by 8 to 10 mmHg and diastolic BP by 5 to 6 mmHg for several hours after dosing, per the FDA prescribing information for sildenafil [12]. If a patient takes tadalafil (which has a 36-hour half-life) the day before or the day of an ABPM study, the entire 24-hr profile will be suppressed. This is a common and underappreciated source of falsely reassuring results.

Nitrates. Sublingual or transdermal nitroglycerin, isosorbide mononitrate, and isosorbide dinitrate lower ambulatory BP through venodilation and preload reduction. Patients using scheduled long-acting nitrates will have systematically lower readings throughout the monitoring period.

Alcohol. Acute alcohol intake lowers BP for 6 to 12 hours through vasodilation, then raises it during withdrawal. A crossover study in Hypertension (AHA journal) found that moderate alcohol consumption (40 g ethanol) lowered ambulatory systolic BP by 4 mmHg during the first 8 hours, followed by a rebound increase of 5 to 7 mmHg during the subsequent 16 hours [13]. The net effect depends on the timing of drinking relative to the monitoring period, making alcohol a particularly unpredictable confounder.

How Timing of Antihypertensives Distorts the Dipping Pattern

Even the drugs intended to treat hypertension can distort ABPM interpretation if their dosing schedule is not documented. The most clinically relevant issue is the timing of antihypertensive administration relative to the start of monitoring.

Short-acting antihypertensives taken in the morning create a classic "sawtooth" pattern on ABPM: BP drops after dosing, rises before the next dose. This peak-trough variation can make daytime means appear acceptable while revealing poor nighttime control. The Hygia Chronotherapy Trial (N=19,084), published in the European Heart Journal, reported that bedtime dosing of at least one antihypertensive converted 40% of non-dippers to dippers [14].

A 2022 counter-study, the TIME trial (N=21,104) published in The Lancet, found no difference in cardiovascular outcomes between morning and evening dosing overall, but ABPM sub-studies still showed distinct circadian BP profiles depending on dose timing [15]. The clinical takeaway is straightforward: the ABPM report must include the exact time each antihypertensive was taken on the study day. Without that information, the dipping pattern is uninterpretable.

The 2023 ESH guideline document states: "ABPM should include a diary noting the timing of medication intake, meals, physical activity, and sleep, as all of these can modify readings and influence clinical interpretation" [1].

Supplements and OTC Products Clinicians Often Miss

Beyond prescription medications, several supplements and OTC products shift ambulatory BP in clinically meaningful ways.

Licorice root (glycyrrhizin). Glycyrrhizin inhibits 11-beta-hydroxysteroid dehydrogenase type 2, causing cortisol to activate mineralocorticoid receptors. Chronic consumption of as little as 50 g/day of licorice candy (containing 75 mg glycyrrhizin) has been shown to raise systolic BP by 3 to 14 mmHg in susceptible individuals, per a systematic review in the Journal of Hypertension [16]. The BP effect persists for one to two weeks after stopping intake, meaning a patient who stopped eating licorice three days before an ABPM study would still show elevated readings.

Caffeine. Habitual caffeine users develop tolerance, so the ABPM effect is minimal (1 to 2 mmHg). But caffeine-naive individuals or those who significantly increase intake on the study day can see transient systolic spikes of 8 to 15 mmHg lasting two to three hours. The ESH 2023 guidelines recommend patients maintain their usual caffeine intake on the ABPM day rather than abstaining or increasing [1].

Oral decongestant combinations. Many cold and allergy products contain pseudoephedrine or phenylephrine combined with an NSAID (e.g., Advil Cold & Sinus contains ibuprofen plus pseudoephedrine). The combined effect on BP is additive.

Herbal supplements. St. John's wort induces CYP3A4 and can reduce blood levels of amlodipine, nifedipine, and other dihydropyridine calcium channel blockers by 50% or more, indirectly raising ambulatory BP in patients who rely on these drugs. Ephedra-containing supplements (still available internationally) produce direct sympathomimetic BP elevation.

Pre-ABPM Medication Review: A Practical Checklist

The 2017 ACC/AHA hypertension guideline recommends screening for secondary and drug-induced hypertension before establishing a diagnosis, and ABPM is the tool most sensitive to these confounders [5]. Here is a practical checklist for clinicians and patients before the monitor is placed:

1. List every medication, including OTC. Ask specifically about NSAIDs, decongestants, and combination cold products.
2. Record dose timing. Note the exact time of each antihypertensive taken on the study day.
3. Flag stimulant medications. Patients on amphetamine or methylphenidate should take their usual dose at the usual time (to reflect their real-world BP profile) unless the clinician specifically wants a drug-free reading.
4. Ask about PDE5 inhibitors. Tadalafil's 36-hour half-life means even a dose taken 24 hours before the study affects results.
5. Document caffeine and alcohol use. Instruct patients to maintain their typical intake.
6. Check for licorice and herbal supplement use. Glycyrrhizin and ephedra are the two most common supplement-related BP elevators.
7. Note recent corticosteroid courses. Even a five-day prednisone burst can alter dipping patterns for one to two weeks after completion.

Failure to perform this review before interpreting ABPM results is the most common reason for misclassifying patients with apparent resistant hypertension. A prospective study in the Journal of Clinical Hypertension (N=611) found that 12.8% of patients referred for resistant hypertension had drug-induced or substance-related BP elevation as the primary cause [17].

When to Repeat ABPM After Medication Changes

If a confounding medication is identified, the question becomes how long to wait before repeating the ABPM. The answer depends on the offending drug's pharmacokinetics.

NSAIDs require a 5 to 7 day washout. Corticosteroid-induced BP and dipping changes may persist 10 to 14 days after discontinuation. Licorice-related hypertension resolves within 1 to 4 weeks depending on the duration and amount of prior consumption [16]. For patients stopping or starting an antihypertensive, most guidelines recommend waiting 2 to 4 weeks on a stable regimen before performing ABPM, allowing steady-state drug levels to be reflected in the ambulatory profile.

The 2023 ESH guidelines recommend repeat ABPM whenever a medication change is expected to alter the 24-hr BP profile, rather than relying on office readings alone [1]. For patients on three or more antihypertensives whose ABPM still shows uncontrolled hypertension, a structured medication washout supervised by a hypertension specialist may be warranted to determine true baseline BP before re-titrating therapy.